About FBB Biomed
FBB Biomed is a company based in Coralville (United States) founded in 2020. FBB Biomed has raised $401 thousand across 2 funding rounds. FBB Biomed offers products and services including FBB Test and Research Blood Tests. FBB Biomed operates in a competitive market with competitors including DermTech, NeuMoDx, Molbio Diagnostics, Kryptos Biotechnologies and Altratech, among others.
- Headquarter Coralville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fbb Biomed, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$401 K (USD)
in 2 rounds
-
Latest Funding Round
$326 K (USD), Seed
Aug 04, 2020
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of FBB Biomed
FBB Biomed offers a comprehensive portfolio of products and services, including FBB Test and Research Blood Tests.
Noninvasive test to detect genes linked to autoimmune diseases for research.
Tools for measuring external influences on neurologic health in studies.
People of FBB Biomed
Unlock access to complete
Funding Insights of FBB Biomed
FBB Biomed has successfully raised a total of $401K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $326 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by FBB Biomed
Investment portfolio details for FBB Biomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - FBB Biomed
Detailed financials for FBB Biomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fbb Biomed Comparisons
Peer comparison for FBB Biomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of FBB Biomed
FBB Biomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, NeuMoDx, Molbio Diagnostics, Kryptos Biotechnologies and Altratech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| Locked | Locked | Locked |
Next-generation molecular detection kits for viral diseases are developed.
|
|
| Locked | Locked | Locked |
Smartphone-based DNA detection platform is developed for diagnostics.
|
Detailed competitors of FBB Biomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fbb Biomed
Complete news archive for FBB Biomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FBB Biomed
FBB Biomed was founded in 2020.
FBB Biomed is headquartered in Coralville, United States. It is registered at Coralville, Iowa, United States.
Howard Urnovitz is the current CEO of FBB Biomed.
FBB Biomed is a funded company, having raised a total of $401K across 2 funding rounds to date.
FBB Biomed was founded in 2020 and is based in Coralville, United States, within the biotechnology sector focused on diagnostics. In-vitro tests for COVID-19 and neurological conditions are developed through a process where finger-stick blood samples are collected from patients, RNA is extracted, and analysis is conducted via qPCR. Clinical reports are then produced and interpreted. Data from blood samples of three relapsing-remitting multiple sclerosis patients have been incorporated.
FBB Biomed's top competitors include DermTech, Molbio Diagnostics and NeuMoDx.
FBB Biomed offers FBB Test and Research Blood Tests.